LNP engineering insights and cell therapy regulatory trends.

Seeking process improvement and support? Our experienced team has answers Join our live Q&A with our cell therapy Fast Trak™ team for insights and answers...

Advancing next-generation T cell therapies requires bridging innovative targeting strategies with scalable, robust manufacturing approaches. Explore how t...

We invite you to watch our webinar on advancing cell therapy manufacturing, with a focus on early-stage and clinical development.

As automated CAR T manufacturing moves toward commercialization, platform selection decisions increasingly depend on objective, comparative data rather tha...

Personalized cancer vaccines (PCVs) are reshaping immuno-oncology. However, translating these therapies into the clinic remains challenging. The progress i...

Gain practical insight into how adeno-associated virus (AAV) production can be scaled from development studies to manufacturing-relevant scale while mainta...

The gene therapy landscape is expanding rapidly, but manufacturing costs remain the primary barrier to commercial and clinical accessibility. Therapy devel...

Ready to accelerate your cell therapy development? Lipid nanoparticles (LNPs) are rapidly emerging as a versatile and scalable delivery platform for cell ...

In this webinar, we explore key considerations and best practices for scaling AAV production, including selecting a transient transfection cell line and sc...